<SEC-DOCUMENT>0001209191-11-051989.txt : 20111018
<SEC-HEADER>0001209191-11-051989.hdr.sgml : 20111018
<ACCEPTANCE-DATETIME>20111018171110
ACCESSION NUMBER:		0001209191-11-051989
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20111018
FILED AS OF DATE:		20111018
DATE AS OF CHANGE:		20111018

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Greene Rick Scott
		CENTRAL INDEX KEY:			0001531483

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		111146274

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0204</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2011-10-18</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001087294</issuerCik>
        <issuerName>CUMBERLAND PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>CPIX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001531483</rptOwnerCik>
            <rptOwnerName>Greene Rick Scott</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>2525 WEST END AVENUE</rptOwnerStreet1>
            <rptOwnerStreet2>SUITE 950</rptOwnerStreet2>
            <rptOwnerCity>NASHVILLE</rptOwnerCity>
            <rptOwnerState>TN</rptOwnerState>
            <rptOwnerZipCode>37203</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Financial Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>No securities beneficially owned</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes></footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Rick S. Greene</signatureName>
        <signatureDate>2011-10-18</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.3_394659
<SEQUENCE>2
<FILENAME>poa.txt
<DESCRIPTION>POA DOCUMENT
<TEXT>
POWER OF ATTORNEY

Know all by these presents, I hereby appoint Jean W. Marstiller, to act as my
agent and attorney-in-fact for the purpose of completing, executing and filing
on my behalf with the Securities and Exchange Commission, the NASDAQ Stock
Market LLC or any other exchange or self-regulatory body, any Form 3 "Initial
Statement of Beneficial Ownership of Securities", Form 4 "Statement of Changes
in Beneficial Ownership of Securities", Form 5 "Annual Statement of Beneficial
Ownership of Securities", Form 144 "Notice of Proposed Sale of Securities",
Schedule 13D pursuant to Rule 13d-101 of the Securities Exchange Act of 1934, or
any other similar form to report securities ownership that may, in the opinion
of any of them be necessary, with respect to any transaction in securities of
Cumberland Pharmaceuticals Inc.

Nothing herein shall relieve me of the responsibility for the accuracy of the
information and representations contained in any Form 3, Form 4, Form 5, Form
144, Schedule 13D, or other similar form completed, executed and filed pursuant
to this power of attorney.

This power of attorney shall supersede all similar prior powers of attorney and
will remain effective as to the agent and attorney-in-fact referred to above
until I revoke or amend it by written notice to such persons or until the
undersigned is no longer required to file Form 3, Form 4, Form 5, Form 144,
Schedule 13D or other similar form completed, executed and filed pursuant to
this power of attorney.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed on this 12th day of October 2011.

					/s/ Rick S. Greene



</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
